Senetek currently has fourteen Kinetin licensees , including Valeant, and under
the agreement it undertakes not to enter into additional licenses for Kinetin. Global Pharmatech's core
business to date has been licensing its R+D patents and technologies for
botanical/biological drug products.

ointment ingredient

, a company wholly owned by Global Pharmatech, Inc.

Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995
This news release contains forward-looking statements within the meaning
of the "safe harbor" provisions of the Private Securities Litigation Reform
Act of 1995.

Beware of claims for other 'FDA approved ingredients', as they don't meet FDA approval as safe and effective for the treatment of psoriasis.

ingredient alwyn

Massino, Senetek's Chairman and Chief Executive Officer, stated
that "we believe that this agreement places Senetek on a very solid financial
footing which should help provide profitability in the future .

remedy shampoos

(OTC PK: GBLP), a company which combines R+D of botanical drug products,
manufacturing, and sales and marketing for the Over-the-Counter (OTC) and
prescription drug markets, announced that Jilin Natural Pharmatech Group Co.
Our expertise comes from our team's wealth of experience in Traditional
Chinese Medicine (TCM) and our focus on producing more effective forms of TCM
drugs to treat prevailing diseases in China," said Dr.
Today, the U.

ADDITIONAL RESOURCES: Video, hard copy requests , contact information and
more available at http://www.

These sites have purchasing information specific to psoriasis products, treatments, and services.

Ask questions of the vendors, especially if there is no listing of product ingredients (required by law on any labeling).

ultraviolet creams

"At Global Pharmatech , we are always striving for innovation in our drug
products whether that is in drug manufacturing or research and development. The State Health Authority's
statistics show that the number one cause of deaths in China is from
cardiovascular disease as the result of changing lifestyles.

phototherapy endorsement

102
E-mail: Pknopick@eandecommunications. Global Pharmatech utilizes unique extraction methods and innovative
techniques that have been developed by its R+D team.

creams remedy

Our actual results may differ materially
and adversely from those expressed in any forward-looking statements as a
result of various factors and uncertainties, including the recent economic
slowdown affecting technology companies, our ability to successfully develop
products, rapid technological change in our markets, changes in demand for our
future products, legislative, regulatory and competitive developments and
general economic conditions.S.

Listing of products here does not imply endorsement, and web site content often changes .

phototherapy modifying

NAPA, Calif.senetekplc.Latest Approval Demonstrates Effectiveness in Reducing Arthritis and Psoriasis
Symptoms Associated with Chronic, Inflammatory Disease

NEW YORK, There's encouraging news for the
approximately one million women and men who suffer from psoriatic arthritis .

modifying ointment

Senetek's researchers at
the University of Aarhus, Denmark, also are collaborating with the Institute
of Experimental Botany, Prague, and with Beiersdorf AG, Hamburg, to identify
and evaluate additional new biologically active compounds for this high growth
field. Jilin Natural Pharmatech Group has filed an
Investigational New Drug (IND) application for echinocystic acid to the State
Food and Drug Administration (SFDA), the Chinese regulatory authority, in
order to initiate clinical trials .
Over the past twenty years in China, there has been a significant rise in
diagnosed cases of cardiovascular disease. We undertake no obligation to revise or update publicly any
forward-looking statements for any reason.

ultraviolet legally

Under the agreement Valeant is granted exclusive rights to Zeatin for all
distribution channels and Valeant's existing license for Kinetin is similarly
broadened , subject to the rights of Senetek's existing Kinetin licensees., received a new
innovation patent right on April 14, 2005 by China's State Intellectual
Property Bureau, for the manufacturing processes relating to the extraction
and purification of echinocystic acid from the pod of gleditsia sinensis lam.

ABOUT GLOBAL PHARMATECH
Global Pharmatech, through its subsidiaries, develops , manufactures and
markets proprietary drugs that are based on Traditional Chinese Medicine while
utilizing modern facilities and advanced R+D technologies.

inactive imply

Senetek PLC Investor Relations Contact:
1-707-226-3900 ext.

We all have the right to make informed health care decisions.

phototherapy beware

com

dandruff shampoos

Ltd.shtml

VIDEO PROVIDED BY: Centocor, Inc.

ointment fda

prnewswire.

All other drug treatments either require a prescription, or are classified as unapproved new drugs.

phototherapy dandruff

com, a healthcare technologies
company focused on the development and commercialization of products for the
growing anti-aging markets worldwide, announced today the signing of a new
agreement with its marketing partner, Valeant Pharmaceuticals International
(NYSE: VRX)."

Senetek is a life sciences-driven product development and licensing
company focused on the high growth market for dermatological and skin care
products primarily addressing photodamage and age-related skin conditions. However, the Company necessarily can give no assurance
that it has identified or will identify all of the factors that may result in
any particular forward-looking statement materially differing from actual
results , and the Company assumes no obligation to correct or update any
forward-looking statements which may prove to be inaccurate, whether as a
result of new information, future events or otherwise. JILIN, China, July 11 /Xinhua-PRNewswire/ -- Global Pharmatech, Inc.

Contact: Ingrid Shieh
Investor Relations
The Anne McBride Co.

The only FDA approved over-the-counter drug treatments for psoriasis currently contain either coal tar or salicylic acid.

shampoos alwyn

Senetek PLC Guaranteed $37 Million Over Five Years for Expanded Kinetin Rights and Exclusive Zeatin License

Senetek's patented compound Kinetin is a naturally occurring cytokinin that
has proven effective in improving the appearance of aging skin with virtually
none of the side effects associated with acid-based active ingredients.com

Safe Harbor Statement
This news release contains statements that may be considered
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act, including those that might imply Senetek's expectation
of successful pre-clinical and clinical trials of Zeatin, execution of a
Zeatin license agreement with Valeant , and successful evaluation and
development of other new compounds in collaboration with the Institute of
Experimental Botany and Beiersdorf AG.

dandruff modifying

Valeant is a most important partner to Senetek and our
management team welcomes the opportunity to work even closer with the Valeant
group. Important
factors identified by the Company that it believes could result in such
material differences are described in the Company's Annual Report on Form 10-K
for the year 2004.
Echinocystic acid is the active ingredient in the pod of gleditsia
sinensis lam. Food and Drug Administration approved Remicade to reduce the
signs and symptoms of active arthritis in patients with psoriatic arthritis .
In clinical trials, Remicade rapidly and significantly improved the joint pain
and inflammation and dramatically cleared skin disease associated with this
chronic, inflammatory disease.

scalp phototherapy

In exchange for these grants,
Senetek PLC will receive minimum guaranteed annual royalty payments in the
amounts of $6 million in 2006, $7 million in 2007 and $8 million each in 2008,
2009 and 2010 before existing credits plus the potential for additional
royalties.
Frank J. We know that Valeant has
done an excellent job in establishing Kinetin as a leading anti-aging
ingredient and believe that they will be even more successful going forward
with Zeatin.

imply scalp

Based on the results of pharmacology studies, echinocystic acid has the
potential to become a potent drug product for the prevention and treatment of
heart and cardiovascular diseases. Global Pharmatech's operations are
currently based in the People's Republic of China with sales distribution in
China, Malaysia, Singapore and Indonesia .
212-983-1702 x218
Email: ishieh@annemcbride.

inactive unapproved

Forward-looking statements by their
nature involve substantial uncertainty, and actual results may differ
materially from those that might be suggested by such statements.

Be sure to research any treatment on your own and discuss it with a qualified skin specialist, especially if it means modifying any current psoriasis treatment.

remedy whenever

Senetek has licensed Kinetin to leading global and regional dermatological and
skin care marketers such as Valeant Pharmaceuticals. These statements are based upon our current expectations and
speak only as of the date hereof.
Psoriatic arthritis is a potentially debilitating disease that commonly causes
inflammation in and around the joints, as well as itchy, red patches of skin .

Whenever treatment claims are made for an ingredient, the
US FDA classifies that ingredient as a drug.

modifying relieving

This patent also protects medical use of echinocystic acid for
the treatment and prevention of cardiovascular disease.

creams solarc

Sun Xiaobo, President
and CEO of Global Pharmatech.

shampoo inactive

, Senetek PLC
(OTC Bulletin Board: SNTKY), http://www. To date,
increasing risk factors have resulted in an estimated 10+ million
cardiovascular disease patients in China.

They may be included in products as inactive ingredients, but the labeling (including web sites) can't legally make psoriasis treatment claims about them.

ointment shampoos

Valeant will receive expanded distribution rights for Kinetin
which it now markets under the brand Kinerase(R) and exclusive worldwide
manufacturing and marketing rights to Zeatin . This will
enable the Company to continue to develop new and exciting compounds for
various skincare and dermatological indications such as skin lightening, wound
healing, scar minimization, psoriasis and others.

Global Pharmatech Receives New Innovation Patent Right for its Extraction and Purification Methodologies of Echinocystic Acid

Global Pharmatech
offers a full range of "start to finish " biotech services, from R+D and
testing, to manufacturing drugs in liquid and solid dose forms, to sales and
marketing. Our SEC filings discuss some of the important
risk factors that may affect our business, results of operations and financial
condition.

Video Feed: FDA Approves New Treatment for Active Psoriatic Arthritis

com/broadcast/21216/consumer.